NovoCure Limited (NVCR)
NASDAQ: NVCR · IEX Real-Time Price · USD
+0.84 (3.77%)
At close: May 24, 2024, 4:00 PM
+0.01 (0.04%)
After-hours: May 24, 2024, 7:35 PM EDT

NovoCure Revenue

NovoCure had revenue of $525.66M in the twelve months ending March 31, 2024, with 0.61% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $138.50M with 13.36% year-over-year growth. In the year 2023, NovoCure had annual revenue of $509.34M, a decrease of -5.30%.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
2.49B USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 2023509.34M-28.50M-5.30%
Dec 31, 2022537.84M2.81M0.53%
Dec 31, 2021535.03M40.67M8.23%
Dec 31, 2020494.37M143.05M40.72%
Dec 31, 2019351.32M103.25M41.62%
Dec 31, 2018248.07M71.04M40.13%
Dec 31, 2017177.03M94.14M113.57%
Dec 31, 201682.89M49.80M150.52%
Dec 31, 201533.09M17.60M113.60%
Dec 31, 201415.49M5.13M49.53%
Dec 31, 201310.36M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
agilon health 4.78B
ICU Medical 2.26B
Progyny 1.11B
ACADIA Pharmaceuticals 813.81M
Twist Bioscience 277.49M
Arvinas 71.30M
Intellia Therapeutics 52.60M
Celldex Therapeutics 6.07M
Revenue Rankings